The firm's consolidated profit after tax (PAT) fell 57.8 per cent year-on-year (YoY) to Rs 55.21 crore due to lower operational income. The specialty chemicals company had posted PAT of Rs 130.85 crore in the year ago quarter (Q4FY22).
In today's intra-day trade, the stock more than halved or plunged 51 per cent from its 52-week high level of Rs 3,842 touched on September 15, 2022. At 10:02 am; the stock was quoting 12 per cent lower at Rs 2,029, as compared to 0.29 per cent rise in the S&P BSE Sensex. The stock has fallen below its previous low of Rs 1,925.05, touched on March 29, 2022.
In Q4FY23, the company’s total income declined 39 per cent YoY to Rs 476.90 crore as against Rs 785.41 crore in Q4FY22. Earnings before interest, taxes, depreciation and amortization (Ebitda) margin contracted 493 bps to 20.68 per cent. The fall in the operating margin was primarily on account of degrowth in pharma and active pharmaceutical ingredient (API) and agro sector.
The management believes the performance of the company will improve gradually in the coming months, and anticipate a return to growth & margin levels similar to those achieved before the onset of the COVID-19 pandemic in due course, which management think is sustainable.
Revenues from the new commenced plants such as DMC, PG, Ethylamines will start contributing to the company’s top line from coming quarters, which in turn can improve the margin profile of the company from Q1FY24, the management said.
Meanwhile, Balaji Amines informed the exchanges that Mr Naveena Thammishetty Chandra, Mr Kashinath Revappa Dhole, Mr Satyanarayana Murthy Chavali, Mr Amarender Reddy Minupuri and Mrs Vimala Behram Madon have resigned as independent directors of the company from the closing hours on May 20 and Mr. Hemanth Reddy Gaddam has also resigned as whole-time director & CFO of the company to focus on subsidiary company Balaji Speciality Chemicals.
The board has inducted Mrs. Suhasini Yatin Shah, Dr. Uma Rajiv Pradhan, Mr. R. Mohan Kumar and Mr. Adabala Sheshagiri Rao to the company’s board.
Mr. Ande Srinivas Reddy, whole-time director will also take charge as CFO and Mr. Rajeshwar Reddy Nomula has been re-designated as whole-time director, the company said.
Balaji Amines is a leading manufacturer of Aliphatic Amines & Speciality Chemicals in India, specialized in manufacturing of Methyl Amines, Ethyl Amines, Derivatives of Amines and other Specialty Chemicals.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)